Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-005392
Filing Date
2014-11-10
Accepted
2014-11-10 16:09:11
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pbyi-10q_20140930.htm 10-Q 1802148
2 EX-10.1 pbyi-ex101_20140930765.htm EX-10.1 51903
3 EX-31.1 pbyi-ex311_2014093093.htm EX-31.1 12336
4 EX-31.2 pbyi-ex312_2014093094.htm EX-31.2 12328
5 EX-32.1 pbyi-ex321_2014093095.htm EX-32.1 9088
6 EX-32.2 pbyi-ex322_2014093096.htm EX-32.2 9103
  Complete submission text file 0001564590-14-005392.txt   6950736

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT pbyi-20140930.xml EX-101.INS 1069989
8 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20140930.xsd EX-101.SCH 32896
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20140930_cal.xml EX-101.CAL 35044
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20140930_def.xml EX-101.DEF 101645
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20140930_lab.xml EX-101.LAB 286446
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20140930_pre.xml EX-101.PRE 217004
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

EIN.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 141208736
SIC: 2834 Pharmaceutical Preparations